Astonea Labs IPO - Detail
Astonea Labs Ltd is set to launch its Initial Public Offering (IPO) from May 27 to May 29, 2025, with a price band of ₹128 to ₹135 per share. The book-built issue aims to raise approximately ₹37.67 crores through a fresh issue, along with an offer for sale of [.] equity shares (face value: ₹10 each). The allotment will be finalized by May 30, 2025, and the shares are scheduled to list on the BSE on June 3, 2025. The IPO reserves 35% for retail investors, 50% for QIBs (Qualified Institutional Buyers), and 15% for HNIs (High Net-Worth Individuals). Financially, the company has demonstrated robust growth, with revenue increasing from ₹67.26 crores in 2023 to ₹80.29 crores in 2024, while profits surged from ₹0.67 crores to ₹3.81 crores during the same period. Given this strong performance, the IPO presents a compelling opportunity for long-term investors seeking sustainable growth in the pharmaceutical and cosmetics manufacturing sector.
Astonea Labs IPO Market Lot
The Astonea Labs IPO minimum market lot is 1000 shares with ₹1,35,000 application amount.
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 1000 | ₹1,35,000 |
Retail Maximum | 1 | 1000 | ₹1,35,000 |
S-HNI Minimum | 2 | 2000 | ₹2,70,000 |
Astonea Labs IPO Details
IPO Open Date: | May 27, 2025 |
IPO Close Date: | May 29, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹128 to ₹135 Per Share |
Issue Size: | Approx ₹37.67 Crores |
Fresh Issue: | Approx ₹37.67 Crores |
Issue Type: | Book Build Issue |
IPO Listing: | BSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
Astonea Labs IPO Valuation – FY2024 (KPI)
Check Astonea Labs IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
KPI | Values |
ROE: | 37.86% |
ROCE: | 22.95% |
EBITDA Margin: | 14.60% |
PAT Margin: | 4.75% |
Debt to equity ratio: | 2.16 |
Earning Per Share (EPS): | ₹5.01 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 31.83% |
Net Asset Value (NAV): | ₹15.75 |
Astonea Labs IPO Company Financial Report
The company reported revenue of ₹80.29 crores in 2024 against ₹67.26 crore in 2023. The company reported profit of ₹3.81 crores in 2024 against profit of ₹0.67 crores in 2023.
Amount ₹ in Crores
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹30.17 | ₹29.60 | ₹0.25 | ₹52.91 |
2023 | ₹67.26 | ₹66.18 | ₹0.67 | ₹64.28 |
2024 | ₹80.29 | ₹75.18 | ₹3.81 | ₹80.89 |
December 2024 | ₹69.69 | ₹64.32 | ₹4.10 | ₹96.52 |
Astonea Labs IPO Dates
The Astonea Labs IPO date is May 27 and the close date is May 29. The Astonea Labs IPO allotment will be finalized on May 30 and the IPO listing on June 3.
IPO Open Date: | May 27, 2025 |
IPO Close Date: | May 29, 2025 |
Basis of Allotment: | May 30, 2025 |
Refunds: | June 2, 2025 |
Credit to Demat Account: | June 2, 2025 |
IPO Listing Date: | June 3, 2025 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Beta Drugs limited | 37.9 | 49.00 | 23.19% | 163.43 | 297.07 Cr. |
Promoters of Astonea Labs IPO
The promoters of the company is Ashish Gulati.
About Astonea Labs IPO
Astonea Labs Ltd is a trusted pharmaceutical and cosmetic manufacturing company with over 35 years of experience, headquartered in Haryana, India. Known for its unwavering commitment to quality and customer satisfaction, the company specializes in flexible, third-party manufacturing solutions tailored to help clients thrive. Astonea Labs produces a diverse range of products, including tablets, capsules, softgels, powders, ointments, creams, and lotions—all adhering to stringent Drug and Cosmetics industry standards. With a strong focus on excellence, the company is dedicated to delivering high-quality formulations that enhance and improve lives worldwide.
Objects of the IPO
Registration in Bolivia, South America – Covering expenses related to regulatory approvals and market entry.
Plant & Machinery for Ointment Production – Procurement and installation of equipment on the 2nd floor of the existing facility to meet international export standards.
Advertising, Marketing & Brand Building – Enhancing market presence and brand recognition.
Hardware & Software Procurement – Investment in technology infrastructure to support operations.
Working Capital Requirements – Funding day-to-day operational and production needs.
General Corporate Purposes – Supporting overall business growth and administrative expenses.
Merchant Bankers
- Oneview Corporate Advisors Pvt. Ltd.
Company Address
Astonea Labs Ltd
House No. 1358,
1st Floor,
Sector-22B,
Phone: +91 9888302323
Email: [email protected]
Website: https://www.astonea.org/
Check Grey market premium at below
(GMP)
Astonea Labs IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/